Hormonal, metabolic and genetic predictors of metformin efficacy in patients with diabetes mellitus and cancer
Aims. To compare hormonal and metabolic profile of type 2 diabetes mellitus patients (T2DM) with or without neoplastic processes with the data from screening for SNPs affecting sensitivity to metformin.To compare the abovementioned parameters including relevant genotype frequency in patients with p...
Guardado en:
Autores principales: | Lev Mikhaylovich Bershteyn, Dmitriy Alexeevich Vasil'ev, Aglaya Gennadievna Ievleva, Tatiana Evgen'evna Poroshina, Evgeny Naumovich Imyanitov |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0ed7f14609844c7ab76c40242bb98951 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Metformin and cancer mortality
por: Lev Mikhaylovich Bershteyn
Publicado: (2010) -
Multidimensional effects of metformin in patients with type 2 diabetes
por: Lyudmila A. Ruyatkina, et al.
Publicado: (2017) -
Metformin effects to carbohydrate and lipids metabolism in impaired glucose tolerance patients.
por: Alexander Vasil'evich Dreval', et al.
Publicado: (2010) -
Efficacy and safety of metformin for the treatment of gestational diabetes: a new approach to the problem
por: Anna I. Sazonova, et al.
Publicado: (2016) -
Diabetes, obesity and cancer: risk and anti-risk factors
por: Lev Mikhaylovich Bershteyn
Publicado: (2012)